Pharma and other healthcare companies love qualitative research. Advisory boards, focus groups, patient interviews, physician discussions, and ethnographic studies have become standard tools for gathering insights. The belief is simple: if you talk to enough people, you’ll understand how they think, feel, and make decisions. I disagree. While qualitative research can be useful for generating hypotheses, I don’t believe key business decisions should be based primarily on qualitative findings. The reason is simple: human emotions, motivations, and decision-making processes are incredibly difficult to put into words.
People in pharma don’t get a cup of coffee without first researching it. However, there comes a time when you need to question your research based on “what you should know”. I’ve found that in qualitative research, people often struggle to put emotions into words, especially in front of others.
People Don’t Really Know Why They Do What They Do
One of the biggest flaws in qualitative research is the assumption that people understand their own behavior. Patients often cannot fully explain why they delayed treatment, stopped taking medication, ignored symptoms, or chose one therapy over another. Physicians may struggle to articulate why they prescribe one drug over another when multiple options appear clinically similar. The reality is that much of human decision-making occurs below the level of conscious awareness.
When researchers ask people why they made a decision, respondents often offer a reasonable answer rather than one that accurately reflects what happened. They’re not lying. They’re simply constructing a narrative that makes sense after the fact. Unfortunately, healthcare marketers and executives frequently mistake these explanations for objective truth.
A great example is the research that I was part of on GLP-1 drugs. We heard a lot about why patients discontinued their use (side effects), but we really had to dig deeper to understand that it was “quality of life issues” and how using GLP-1s made them miss out on some social gatherings around meals. The Product Director also said that his market research people mentioned that a lot of people went on GLP-1s because of “fat-shaming”.
Emotions Are Difficult to Express
Healthcare decisions are often driven by emotions such as fear, anxiety, hope, uncertainty, trust, frustration, and event triggers. The problem is that emotions are notoriously difficult to describe. Ask a patient how they felt when they received a diagnosis, and you’ll get words. What you won’t get is the full emotional experience. Language is an imperfect tool for expressing complex feelings.
Patients may say they were “worried,” but what does that mean? Were they worried about dying? Losing their job? Becoming dependent on others? Financial ruin? Family responsibilities?
A single word rarely captures the depth of emotion driving healthcare decisions. As a result, qualitative researchers often end up interpreting what respondents mean rather than measuring what they actually feel.
The Researcher’s Bias Never Disappears
Another challenge is that qualitative research is highly dependent on interpretation. Researchers decide which questions to ask. Moderators decide when to probe deeper. Analysts decide which comments are important. Report writers decide which themes to emphasize. At every stage, human judgment influences the outcome.
Two researchers can review the same interview transcripts and arrive at different conclusions. Both may be intelligent and experienced. Both may be convinced they are right. That should concern anyone making multimillion-dollar business decisions.
Small Samples Create Big Risks
Healthcare companies routinely make strategic decisions based on interviews with a handful of physicians or patients. Sometimes those samples are astonishingly small. Ten physicians. Twenty patients. A few focus groups.
Yet the findings are often presented as if they represent an entire market.
The problem is that healthcare markets are incredibly diverse. Patient experiences vary by geography, age, socioeconomic status, disease severity, insurance coverage, and countless other factors. What sounds like a powerful insight in a focus group may be completely irrelevant to the broader population.
What People Say and What People Do Are Often Different
Perhaps the biggest reason I distrust qualitative research is that stated behavior and actual behavior are frequently disconnected. Patients say they want one thing and do another. Physicians say they rely on clinical evidence yet may be influenced by habit, peer recommendations, formulary restrictions, or patient requests. Consumers routinely claim they dislike advertising while simultaneously purchasing products promoted through advertising.
If healthcare organizations want to understand behavior, they should spend more time studying actual behavior and less time studying explanations of behavior. Digital analytics, prescription data, claims data, website behavior, search behavior, and observational studies often reveal patterns that interviews miss entirely.
Use Qualitative Research Carefully
I’m not arguing that qualitative research has no value. It can help uncover issues worth exploring. It can identify language patients use. It can generate hypotheses. It can help researchers understand context.
But that’s very different from using qualitative findings as the primary basis for major business decisions. Too often, healthcare organizations treat qualitative research as if it reveals objective truth. It doesn’t.
At best, qualitative research offers a collection of stories, opinions, perceptions, and interpretations. Those stories may be valuable, but they should be validated using larger, more objective data sources before millions of dollars are invested in strategy changes, product launches, messaging campaigns, or patient programs.
The healthcare industry places enormous faith in qualitative research because it feels human. It feels insightful. It feels like we’re hearing the authentic voice of patients and physicians. But feelings are not facts. People struggle to explain their emotions, often misunderstand their own motivations, and frequently behave differently than they claim they will.
That doesn’t make qualitative research useless. It becomes dangerous when treated as evidence rather than as a starting point for further investigation.
When important business decisions are on the line, healthcare organizations should trust what people do more than what they say.

